ProjectELEVATE 3101-304-002

Basic data

Title:
ELEVATE 3101-304-002
Duration:
12/18/2020 to 12/18/2022
Abstract / short description:
A phase 3, multicenter, randomized, double-blind, placebo-controlled, parallel-group study to evaluate the efficacy, safety, and tolerability of oral atogepant for the prophylaxis of migraine in participants with episiodic migraine who have perviously failed 2 to 4 classes of oral prophylactic treatments.

Involved staff

Managers

Faculty of Medicine
University of Tübingen
University Department of Neurology
Hospitals and clinical institutes, Faculty of Medicine

Contact persons

University Department of Neurology
Hospitals and clinical institutes, Faculty of Medicine

Local organizational units

Department of Neurology and Epileptology
University Department of Neurology
Hospitals and clinical institutes, Faculty of Medicine

Funders

Marlow, United Kingdom
Help

will be deleted permanently. This cannot be undone.